Creative Biolabs-Immuno-oncology

Anti-DNM2 (clone 5LE4IC2EF3) SynExpress trc-mSc-cJ-H Modified CD8+ T cells (CAT#: ITS-1224-CR2203)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DNM2 (clone 5LE4IC2EF3). We employs the Lentivirus (trc-mScarlet-c-Jun-HindIII) vector components and the SynExpress system of the Exons RNA Editing/Negative feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DNM2
Clone
5LE4IC2EF3
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
mScarlet
Promoter
trc
Effector Gene
c-Jun
Insertion Sites
HindIII
Gene Modification
RNA Editing
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.92
Cell Culture
Suspension Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.